|
Volumn 15, Issue 4, 2009, Pages 380-383
|
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BISOPROLOL;
CALCIUM;
CALCIUM CHANNEL BLOCKING AGENT;
FLECAINIDE;
METOPROLOL;
RYANODINE RECEPTOR 2;
VERAPAMIL;
ADULT;
ANIMAL MODEL;
ARTICLE;
CALCIUM TRANSPORT;
CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA;
CHILD;
CLINICAL TRIAL;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DEPOLARIZATION;
DRUG INHIBITION;
FEMALE;
HEART RATE;
HUMAN;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
PROBABILITY;
PROPHYLAXIS;
SARCOPLASMIC RETICULUM;
ANIMALS;
ANTI-ARRHYTHMIA AGENTS;
ARRHYTHMIAS, CARDIAC;
CALCIUM;
CHILD;
FLECAINIDE;
HEART RATE;
HUMANS;
MALE;
MICE;
POLYMORPHISM, GENETIC;
RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;
SYNDROME;
TACHYCARDIA, VENTRICULAR;
MUS;
|
EID: 64149085800
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.1942 Document Type: Article |
Times cited : (495)
|
References (18)
|